Program Speakers
Dan Donovan, David Farber, Preeya Noronha Pinto
Description
This webinar will analyze the legal, regulatory, ethical and public relations challenges surrounding patient requests for expanded access to investigational drugs and biologics, including threats to the integrity of the clinical trial process, concerns about liability exposure, and the prospect of reputational harm. The panel will examine ongoing federal and state efforts to streamline the process and explore alternative policy solutions designed to offer a pathway forward that may enable manufacturers to more effectively navigate patient requests.
You may register for the program here.
If you have questions that are not addressed during the program, please contact one of the speakers and they will be happy to answer them.
If you would like to receive CLE credit for this program, please complete this linked form and return to King & Spalding (see instructions on form).
Thank you for your interest in our e-Learn Pharma Series. To send a request to have your name placed on the e-Learn invitation list, click here.
Contact
Kristina Sooy
Professional Development Coordinator
King & Spalding LLP
1180 Peachtree Street NE
Atlanta, GA 30309
+1 404 572 3042 Direct
ksooy@kslaw.com